MSDC 0160
CAS: 146062-49-9
Ref. TM-T2607
1mg | 35.00 € | ||
2mg | 50.00 € | ||
5mg | 77.00 € | ||
10mg | 100.00 € | ||
25mg | 154.00 € | ||
50mg | 197.00 € | ||
100mg | 350.00 € | ||
1mL*10mM (DMSO) | 83.00 € |
Product Information
- MSDC0160
- Mitoglitazone
- CAY10415
- 5-[[4-[2-(5-Ethyl-2-pyridinyl)-2-oxoethoxy]phenyl]methyl]-2,4-thiazolidinedione
- 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)-2-oxoethoxy]phenyl]methyl]-
- CAY 10415
MSDC 0160 (CAY10415) is a prototype mTOT-modulating insulin sensitizer being used in trials studying the treatment of Type 2 Diabetes and Alzheimer's Disease.
Chemical properties
Technical inquiry about: TM-T2607 MSDC 0160
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.